Navigation Links
United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals

United Kingdom is lagging in innovation, as shown by the market share of new medicines in various countries, including primary care and hospital markets. Reports from various sources prove that Europe has shown very low growth in the field of pharmaceuticals and hospital care//.

Europe has a new plan in order to counter the worsening competitive position of its biopharmaceutical enterprises. The policy is nominally based on a report submitted by Boston based international consultancy Charles River Associates (CRA) to the European Commission to investigate the status and reasons for Europe’s decline in Pharma industry.

Although the US market experienced similar landslides it has been able to grow to higher proportion in the field of new biologics. This is not happening in the case of Europe. “The decline is real and is likely to get worse,” noted independent biotech consultant David Glover, former research director of Cambridge Antibody Technology. Many young European firms, he said, are becoming disillusioned with the lack of reward for innovation.

European Commission Vice president Gunter Verheugen has announced a policy for referendum of the Europe’s biotech policy. The first aspect would be to double the financial support for life sciences research, taken from the six year, $132 billion Research Framework program that begins in 2007. The second aspect would be greasing the wheels of safety and efficacy testing for new types of medicines. The third policy would be to resolving a patchwork of different national systems for drug pricing, which” place a significant burden on industry and can delay access to the market.” The last policy of restricting on patients access to information on new medicines are to be considered.

Verheugen is confident that the program will deliver some concrete results within three years.

Source: Nature Biotechnoogy
'"/>




Page: 1

Related medicine news :

1. Scientists plan human cloning clinic in the United States
2. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
3. United Kingdom to perform its first Live Liver Transplant
4. Inhospitable Response Curtail Growth Of Specialty Hospitals: United States
5. United Kingdom: Farmers Cautioned To Plan Adequately For Bird-Flu
6. Bird-Flu Causes Alarm in United Kingdom.
7. 2010 AIDS Target May Misfire, Warns United Nations
8. AIDS Meet Ends Without Firm Commitments From Donors Dharam Shourie United Nations
9. United Nations draws flak Due to Lukewarm AIDS Prevention Measures
10. Chinese Poultry Smuggled into United States
11. United Kingdom: Making the most of sunshine without the cream
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 28, 2017 , ... ... corrosive ions found in power plant water and steam. , Chlorides and sulfates ... and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions at ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... more patients desire to achieve the “perfect smile.” The National Association of Dental ... well as what dentists should be aware of when utilizing dental laboratories and ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice Treatment ... City March 13-16, was a busy spot this year. Liz Solovay and Adrian ... for preventing outbreaks among camp communities during the upcoming 2017 camping season. “Lice ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... Thank you ... Diego on February 8-10. , This event was exclusive to providers and offered ... , The meeting took place at the Manchester Grand Hyatt where attendees gathered for ...
(Date:3/27/2017)... ... ... New patients who have sleep apnea in Aurora, CO, can now ... Sleep apnea is often left untreated because patients are not familiar with common symptoms ... , Dr. Braasch seeks to raise awareness of sleep apnea in Aurora, CO, and ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017   Pulmatrix, Inc . (NASDAQ: PULM), a clinical ... pulmonary diseases, today announced that it has added two experts ... asthma to its Scientific Advisory Board . ... B. Moss , MD, former chief of the Pediatric Pulmonary ... Center at Stanford University, and David ...
(Date:3/27/2017)... FRANCISCO , March 27, 2017 ... expected to reach USD 16.0 billion by 2025, according ... The growing prevalence of chronic diseases is anticipated to ... chemistry analyzers, which thereby widens the scope for growth ... geriatric and bariatric population, which is highly susceptible to ...
(Date:3/27/2017)... BOSTON , March 27, 2017 ... pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), ... commercialization of innovative therapies based upon tetracycline chemistry, ... sarecycline for the treatment of moderate to severe ... Sarecycline is a once-daily, oral, narrow spectrum tetracycline-derived ...
Breaking Medicine Technology: